Vyoo Agency

Name

Vyoo Agency

Legal name

VYOO Agency

Website

https://vyoo-agency.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Health Economics & Market Access Consulting

NAICS

Management Consulting Services (54161), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK)

akta.pro secondary industries

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)

Keywords

• Health economics consulting
• Market access services
• Medico-economic studies
• HEOR consulting
• Pharmaceutical reimbursement

Headquarters

HQ city

Villeurbanne

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Subscription Database Access: Vyoo Agency generates recurring revenue through subscription-based access to its online efficiency opinions database (efficience.vyoo-agency.com). Subscribers pay for access to search, filter, and review HAS/CEESP efficiency opinions by therapeutic area, dates, evaluation type, objections, modeling choices, and ICER values.
2. Professional Services (HEOR Consulting): Vyoo Agency provides specialized health economics and outcomes research consulting services including medico-economic studies, efficiency dossiers for HAS/CEESP, market access support, evidence synthesis, and training. These services are billed as project-based professional services engagements to pharmaceutical companies, medical device manufacturers, and diagnostics companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Vyoo Agency provides health economics and market access consulting services to pharmaceutical, medical device, and diagnostics companies, including medico-economic studies (budget impact, cost-effectiveness, cost-minimization, cost-consequence models), preparation and submission of efficiency dossiers for the French HAS/CEESP, market access strategy and pricing/reimbursement support, and evidence synthesis (systematic literature reviews and network meta-analysis). The agency also operates a subscription-based online database (efficience.vyoo-agency.com) that provides searchable, real-time access to HAS/CEESP efficiency opinions, supported by training and medical communication services.

Product overview

Vyoo Agency is a specialized health economics and market access consultancy offering a portfolio of services rather than a unified software platform. Core offerings include health economic studies and modeling, preparation of efficiency dossiers for French regulatory authorities (HAS/CEESP), market access strategy support, and evidence synthesis services including network meta-analysis. The company also operates a subscription-based online platform (efficience.vyoo-agency.com) providing searchable access to HAS efficiency opinions. Supporting services include training, team support, and medical communication. The company has expertise spanning multiple therapeutic areas including oncology, rare diseases, and gene/cell therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Health Economic Studies (Études médico-économiques) Design and execution of health economic studies including budget impact models, cost-effectiveness analyses, cost-minimization, and cost-consequence models. Includes conception or adaptation of country-specific models, cost data collection, literature reviews, simulations, and technical report preparation. Targeted at pharmaceutical companies, medical device manufacturers, and diagnostics firms.
• Health Economic Dossiers (HAS/CEESP) Preparation and submission of efficiency dossiers to the French Haute Autorité de Santé (HAS) / CEESP for reimbursement assessment. Includes strategic advice on medico-economic strategies, full dossier preparation and writing, technical support during evaluation (early meetings, technical exchanges, contradictory phase), and strategic advice on utilization of opinions. Targeted at pharmaceutical and medical device companies requiring French market access.
• Market Access Services Comprehensive market access support including value proposition definition, strategic price and reimbursement analysis, coverage application preparation (including derogation and common law pathways), support during the evaluation process (pre-submission meetings, hearings, price negotiation), and capitalization of clinical and medico-economic arguments. Targeted at pharmaceutical and medical device companies seeking market entry and reimbursement in France.
• Evidence Synthesis & Network Meta-Analysis Systematic and targeted literature reviews, network meta-analysis (NMA) services including critical review, complete NMA realization (data selection, network definition, analysis, report writing), and strategic utilization of results for access and efficiency assessment. Targeted at pharmaceutical and medical device companies requiring evidence synthesis to support submissions.
• HAS Efficiency Opinions Online Database (Base de données des avis d'efficience HAS) Subscription-based online database providing access to HAS/CEESP efficiency opinions, with a user-friendly interface allowing searches by therapeutic area, dates, evaluation types (first registration, re-registration, reassessment, indication extension), objections received, modeling choices, and ICER validity and value. Real-time updates within 24 hours of HAS publication, with email alerts for new opinions. Targeted at pharmaceutical, medical device, and diagnostics companies needing rapid access to HAS efficiency opinions.
• Training & Team Support (Formation & accompagnement) Training sessions on health economics, modeling, and market access; popularization of medico-economic publications and efficiency opinions; development of objection response materials (price and medico-economic themes); and elaboration of medico-marketing argumentation tools based on economic and medico-economic data. Targeted at pharmaceutical and medical device client teams.
• Medical Communication Services Medical writing for peer-reviewed journals and poster preparation for scientific congresses. Targeted at pharmaceutical and medical device companies, as well as healthcare research organizations.

Quantifiable outcome

• 45 dossiers submitted to the French HAS
• +4 more outcomes

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators7 records

Recent moves2 records

Expansion highlights4 records

Broad incumbents

• ICON plc: Global CRO with HEOR and market access capabilities (including via MAPI and the former Evidera-adjacent assets) — broad incumbent offering overlapping solutions to large pharma.
• IQVIA: Global CRO with large Real-World Evidence, HEOR, and market access practices — competes with Vyoo on enterprise pharma HEOR engagements and offers a much broader service portfolio.
• Charles River Associates (Life Sciences Practice): Global consulting firm with a Life Sciences practice covering HEOR, market access, and pricing strategy — competes with Vyoo on strategic pharma engagements and serves similar customers.

Direct peers

• PHMR (Pharmaceutical Healthcare and Market Research): Independent HEOR, market access, and pricing consultancy headquartered in the UK with European reach — closely comparable niche positioning to Vyoo with similar dossier and evidence-generation offerings.
• Evidera: Global HEOR, RWE, and market access consultancy (now part of Thermo Fisher's PPD) — the leading boutique-to-mid-tier HEOR peer that competes head-to-head with Vyoo for pharma health economics and dossier work in Europe.
• Putnam Associates: Specialized market access and HEOR strategy consulting firm serving pharma and biotech — closely comparable in service mix (value strategy, pricing, evidence generation) and customer base to Vyoo.
• BresMed Health Solutions: HEOR, market access, and health economics consultancy with strong European footprint — directly comparable in offering NMA, modeling, and HTA dossier preparation for pharma clients.
• Lattice Group: Specialized consultancy providing HEOR, market access, and pricing strategy to pharma — close peer in service scope and customer segment despite different geographic emphasis.
• Wickenstones: Market access and HEOR consulting firm working with pharma and biotech on pricing, reimbursement, and evidence generation — highly comparable service portfolio and client segments to Vyoo.
• Alira Health: International healthcare consulting firm with dedicated market access, HEOR, and evidence services — directly competitive in France and Europe for similar pharma use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/vyoo-agency

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vyoo Agency